By Business/Source
Currency:USD
2026/Q2
Stock NameRevenueRatio
Pen Needles154.7M69.75%
Safety34.3M15.46%
Syringes26.3M11.86%
Other4M1.80%
Contract Manufacturing2.5M1.13%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States579.1M53.60%
International501.3M46.40%